Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia

Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer

(2015) Kyung Park et al.   NEOPLASIA

Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy

(2012) T. Van der Kwast et al.   EUROPEAN JOURNAL OF CANCER

Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer

(2012) Alcides Chaux et al.   MODERN PATHOLOGY

The Utility of ERG/P63 Double Immunohistochemical Staining in the Diagnosis of Limited Cancer in Prostate Needle Biopsies

(2011) Oksana Yaskiv et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas

(2011) Alcides Chaux et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients

(2011) T. L. Lotan et al.   CLINICAL CANCER RESEARCH

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas

(2011) Antoun Toubaji et al.   MODERN PATHOLOGY

Atypical Cribriform Lesions of the Prostate: Relationship to Prostatic Carcinoma and Implication for Diagnosis in Prostate Biopsies

(2010) Rajal B. Shah et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

ETS Gene Aberrations in Atypical Cribriform Lesions of the Prostate

(2010) Bo Han et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

(2010) Tarek A. Bismar et al.   BJU INTERNATIONAL

Detection of TMPRSS2 Gene Deletions and Translocations in Carcinoma, Intraepithelial Neoplasia, and Normal Epithelium of the Prostate by Direct Fluorescence In Situ Hybridization

(2010) Shengle Zhang et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Intraductal Carcinoma of the Prostate Without Invasive Carcinoma on Needle Biopsy: Emphasis on Radical Prostatectomy Findings

(2010) Brian D. Robinson et al.   JOURNAL OF UROLOGY

TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features

(2010) Samson W Fine et al.   MODERN PATHOLOGY

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

(2010) B Furusato et al.   PROSTATE CANCER AND PROSTATIC DISEASES

A Robust Immunohistochemical Assay for Detecting PTEN Expression in Human Tumors

(2010) Zaina Sangale et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy

(2009) Anuradha Gopalan et al.   CANCER RESEARCH

PTENgenomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

(2009) Kanishka Sircar et al.   JOURNAL OF PATHOLOGY

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

(2009) Bo Han et al.   MODERN PATHOLOGY

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

(2009) Jennifer C King et al.   NATURE GENETICS

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

(2009) Brett S Carver et al.   NATURE GENETICS

Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications

(2008) J.-M. Mosquera et al.   CLINICAL CANCER RESEARCH

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate

(2008) Olaf Bettendorf et al.   GENES CHROMOSOMES & CANCER

ATP modulates PTEN subcellular localization in multiple cancer cell lines

(2008) Glenn P. Lobo et al.   HUMAN MOLECULAR GENETICS

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

(2008) Maisa Yoshimoto et al.   MODERN PATHOLOGY